Arovella Therapeutics Limited (ALA.AX)
AUD 0.08
(1.25%)
AUD 0.08
(1.25%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | - AUD | 0.0% |
| 2023 | - AUD | -100.0% |
| 2022 | 77.45 Thousand AUD | 2724.73% |
| 2021 | 2742.00 AUD | -35.33% |
| 2020 | 4240.00 AUD | -74.92% |
| 2019 | 16.9 Thousand AUD | -35.39% |
| 2018 | 26.17 Thousand AUD | -98.55% |
| 2017 | 1.8 Million AUD | 0.0% |
| 2016 | - AUD | 0.0% |
| 2015 | - AUD | -100.0% |
| 2014 | 1.87 Million AUD | 212.5% |
| 2013 | 600 Thousand AUD | 0.0% |
| 2012 | - AUD | -100.0% |
| 2011 | 60.59 Thousand AUD | -95.33% |
| 2010 | 1.29 Million AUD | -27.06% |
| 2009 | 1.77 Million AUD | 33.3% |
| 2008 | 1.33 Million AUD | -14.88% |
| 2007 | 1.56 Million AUD | 7.36% |
| 2006 | 1.46 Million AUD | 238.24% |
| 2005 | 431.91 Thousand AUD | -5.91% |
| 2004 | 459.03 Thousand AUD | 13.46% |
| 2003 | 404.56 Thousand AUD | 799.03% |
| 2002 | 45 Thousand AUD | 0.0% |
| 2001 | - AUD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q4 | - AUD | 0.0% |
| 2024 Q2 | - AUD | 0.0% |
| 2024 FY | - AUD | 0.0% |
| 2024 Q3 | - AUD | 0.0% |
| 2024 Q1 | - AUD | 0.0% |
| 2023 Q2 | - AUD | 0.0% |
| 2023 Q3 | - AUD | 0.0% |
| 2023 Q4 | 77.45 Thousand AUD | 0.0% |
| 2023 FY | - AUD | -100.0% |
| 2023 Q1 | - AUD | -100.0% |
| 2022 Q1 | 111.79 Thousand AUD | 3977.1% |
| 2022 FY | 77.45 Thousand AUD | 2724.73% |
| 2022 Q4 | 77.45 Thousand AUD | 0.0% |
| 2022 Q3 | 77.45 Thousand AUD | -30.72% |
| 2022 Q2 | 111.79 Thousand AUD | 0.0% |
| 2021 Q1 | 38.06 Thousand AUD | 797.71% |
| 2021 Q4 | 2742.00 AUD | 0.0% |
| 2021 Q3 | 2742.00 AUD | -92.8% |
| 2021 FY | 2742.00 AUD | -35.33% |
| 2021 Q2 | 38.06 Thousand AUD | 0.0% |
| 2020 Q2 | 41.09 Thousand AUD | 0.0% |
| 2020 Q3 | 4240.00 AUD | -89.68% |
| 2020 FY | 4240.00 AUD | -74.92% |
| 2020 Q4 | 4240.00 AUD | 0.0% |
| 2020 Q1 | 41.09 Thousand AUD | 143.03% |
| 2019 Q3 | 16.9 Thousand AUD | 6.84% |
| 2019 Q2 | 15.82 Thousand AUD | 0.0% |
| 2019 FY | 16.9 Thousand AUD | -35.39% |
| 2019 Q1 | 15.82 Thousand AUD | -39.53% |
| 2019 Q4 | 16.9 Thousand AUD | 0.0% |
| 2018 Q1 | 2.05 Million AUD | 13.86% |
| 2018 Q2 | 2.05 Million AUD | 0.0% |
| 2018 Q4 | 26.17 Thousand AUD | 0.0% |
| 2018 Q3 | 26.17 Thousand AUD | -98.72% |
| 2018 FY | 26.17 Thousand AUD | -98.55% |
| 2017 Q3 | 1.8 Million AUD | 0.0% |
| 2017 FY | 1.8 Million AUD | 0.0% |
| 2017 Q4 | 1.8 Million AUD | 0.0% |
| 2017 Q2 | - AUD | 0.0% |
| 2017 Q1 | - AUD | 0.0% |
| 2016 Q4 | - AUD | 0.0% |
| 2016 Q1 | 1.73 Million AUD | 0.0% |
| 2016 Q3 | - AUD | -100.0% |
| 2016 Q2 | 1.73 Million AUD | 0.0% |
| 2016 FY | - AUD | 0.0% |
| 2015 Q2 | - AUD | 0.0% |
| 2015 FY | - AUD | -100.0% |
| 2015 Q4 | - AUD | 0.0% |
| 2015 Q3 | - AUD | 0.0% |
| 2015 Q1 | - AUD | -100.0% |
| 2014 FY | 1.87 Million AUD | 212.5% |
| 2014 Q2 | 1.9 Million AUD | 0.0% |
| 2014 Q3 | 1.87 Million AUD | -1.32% |
| 2014 Q1 | 1.9 Million AUD | 216.67% |
| 2014 Q4 | 1.87 Million AUD | 0.0% |
| 2013 Q2 | 1.32 Million AUD | 0.0% |
| 2013 Q3 | 600 Thousand AUD | -54.72% |
| 2013 Q4 | 600 Thousand AUD | 0.0% |
| 2013 FY | 600 Thousand AUD | 0.0% |
| 2013 Q1 | 1.32 Million AUD | 0.0% |
| 2012 Q4 | - AUD | 0.0% |
| 2012 FY | - AUD | -100.0% |
| 2011 FY | 60.59 Thousand AUD | -95.33% |
| 2011 Q4 | - AUD | 0.0% |
| 2010 FY | 1.29 Million AUD | -27.06% |
| 2010 Q4 | 1.26 Million AUD | 0.0% |
| 2009 FY | 1.77 Million AUD | 33.3% |
| 2009 Q4 | 1.8 Million AUD | 0.0% |
| 2008 Q4 | 220.05 Thousand AUD | 0.0% |
| 2008 FY | 1.33 Million AUD | -14.88% |
| 2007 Q4 | 1.56 Million AUD | 0.0% |
| 2007 FY | 1.56 Million AUD | 7.36% |
| 2006 FY | 1.46 Million AUD | 238.24% |
| 2006 Q4 | 1.46 Million AUD | 0.0% |
| 2005 FY | 431.91 Thousand AUD | -5.91% |
| 2005 Q4 | 431.91 Thousand AUD | 0.0% |
| 2004 FY | 459.03 Thousand AUD | 13.46% |
| 2004 Q4 | 449.77 Thousand AUD | 0.0% |
| 2003 Q4 | 259.51 Thousand AUD | 0.0% |
| 2003 FY | 404.56 Thousand AUD | 799.03% |
| 2002 FY | 45 Thousand AUD | 0.0% |
| 2001 FY | - AUD | 0.0% |